Acrocyanosis after neoadjuvant ipilimumab plus nivolumab: a case report

Clin Exp Rheumatol. 2020 Sep-Oct;38(5):1031-1032. Epub 2020 Apr 17.

¹ Department of Medical Oncology, and Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
² Department of Rheumatology and Clinical Immunology, and Department of Internal Medicine, Amsterdam UMC, the Netherlands.
³ Department of Internal Medicine, Amsterdam UMC, the Netherlands, the Netherlands.
⁴ Department of Rheumatology and Clinical Immunology, Amsterdam UMC, the Netherlands.
⁵ Department of Medical Oncology, and Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands. c.blank@nki.nl.

No abstract available

Publication types